No Data
Qingdao Vland Biotech INC. (603739.SH): Currently, there are no pesticide products being produced.
On May 7, Gelonghui reported that Qingdao Vland Biotech INC. (603739.SH) stated on the investor interaction platform that the company is currently not producing pesticide products. The products involved in the veterinary medicine Industry include Veterinary Biological Products, Veterinary Chemical Drugs, and Veterinary Traditional Chinese Medicine formulations, primarily used for disease prevention and treatment in poultry and livestock. The company is the first domestic research unit for new chemical drugs for pets and has developed new veterinary drug products in the field of pet disease prevention and control, including those for skin diseases, arthritis, and deworming, although they currently represent a small proportion of revenue. The company will continue to develop and deepen its presence in the pet field, increasing the research and development reserves for pet drugs and building the marketing team.
Qingdao Vland Biotech INC. (603739.SH) reported a net income of 9.5768 million yuan in the first quarter, a decrease of 24.73% year-on-year.
Gelonghui, April 26 - Qingdao Vland Biotech INC. (603739.SH) released its first-quarter report, achieving total operating revenue of 0.31 billion yuan in the first quarter of 2025, a year-on-year increase of 8.16%; the net income attributable to shareholders of the parent company was 9.5768 million yuan, a year-on-year decrease of 24.73%; the EPS was 0.04 yuan.
2024 Annual Report of Qingdao Weilan Biology Co., Ltd.
Summary of the 2024 Annual Report of Qingdao Weilan Biology Co., Ltd
Announcement of the main operating data of Qingdao Weilan Biology Co., Ltd. for the first quarter of 2025
Qingdao Weilan Biology Co., Ltd. Report for the first quarter of 2025
